Journal article · 1995 · Open access

Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients

The Meropenem Study Group of Leuven, London and Nijmegen

Journal of Antimicrobial Chemotherapy, 36(1), 185–200 · Published 1 July 1995 · DOI 10.1093/jac/36.1.185

Open PDFView at the publisherCite this paper

In brief

“Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients” is a 1995 journal article by The Meropenem Study Group of Leuven, London and Nijmegen, published in Journal of Antimicrobial Chemotherapy. OpenAlex counts 86 citations as of 19 November 2026. It is open access: the full text is free to read at Journal of Antimicrobial Chemotherapy.

Citations
86
Most cited in
2012 (3)
Field-weighted impact
6.15
References
24
Authors
1

Abstract

The efficacies of meropenem, a novel carbapenem, and ceftazidime, as empirical therapy of febrile neutropenic patients, were compared in a prospective, randomized clinical trial. One hundred and twelve adult patients were given meropenem 1 g tds iv for 153 episodes of fever, while 109 patients received ceftazidime 2 g tds iv for 151 episodes. All patients survived the first 3 days of therapy and, by the end of the treatment courses, 67 (44%) episodes had responded to meropenem, compared with 62 (41%) to ceftazidime. Eighty (53%) episodes initially treated with ceftazidime and 63 (41%) episodes treated with meropenem were considered to have failed treatment because it was thought necessary to administer additional antibacterial agents; however, modifications were made twice as often because of fever that persisted beyond 2-3 days than because of obvious causes of failure such as persistent infection. Three patients in the ceftazidime group and five in the meropenem group died. Meropenem was well tolerated, with no reports of nausea or toxicity to the central nervous system. Although ceftazidime was shown in the present study to be as effective as meropenem, the broader spectrum of activity of meropenem against Gram-positive cocci suggests that it might be more appropriate as empirical therapy of febrile neutropenic patients who are at high risk of acquiring infections caused by these bacteria.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

The Meropenem Study Group of Leuven, London and Nijmegen. (1995). Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. Journal of Antimicrobial Chemotherapy, 36(1), 185–200. https://doi.org/10.1093/jac/36.1.185

MLA 9

The Meropenem Study Group of Leuven, London and Nijmegen. “Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients.” Journal of Antimicrobial Chemotherapy, vol. 36, no. 1, 1995, pp. 185–200. https://doi.org/10.1093/jac/36.1.185.

Chicago

The Meropenem Study Group of Leuven, London and Nijmegen. 1995. “Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients.” Journal of Antimicrobial Chemotherapy 36 (1): 185–200. https://doi.org/10.1093/jac/36.1.185.

Harvard

The Meropenem Study Group of Leuven, London and Nijmegen (1995) ‘Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients’, Journal of Antimicrobial Chemotherapy, 36(1), pp. 185–200. doi:10.1093/jac/36.1.185.

IEEE

The Meropenem Study Group of Leuven, London and Nijmegen, “Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients,” Journal of Antimicrobial Chemotherapy, vol. 36, no. 1, pp. 185–200, 1995, doi: 10.1093/jac/36.1.185.

BibTeX

@article{themeropenemstudygroupofleuvenlondonandnijmegen1995equivalent,
  title     = {{Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients}},
  author    = {The Meropenem Study Group of Leuven, London and Nijmegen},
  journal   = {Journal of Antimicrobial Chemotherapy},
  year      = {1995},
  volume    = {36},
  number    = {1},
  pages     = {185--200},
  doi       = {10.1093/jac/36.1.185},
  url       = {https://doi.org/10.1093/jac/36.1.185}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201233
201311
201411
201522
201811
201922
202011
202411

Its field-weighted citation impact is 6.15: it has been cited 6.15 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections

  • meropenem
  • ceftazidime
  • febrile neutropenia
  • empirical antibiotic therapy
  • carbapenems
  • Gram-positive cocci
  • treatment failure
  • drug efficacy comparison

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

The Meropenem Study Group of Leuven, London and Nijmegen. (1995). Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. Journal of Antimicrobial Chemotherapy, 36(1), 185–200. https://doi.org/10.1093/jac/36.1.185

How many times has this paper been cited?

86 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Antimicrobial Chemotherapy: sign in and open the PDF from this page.

Who wrote this paper?

The Meropenem Study Group of Leuven, London and Nijmegen.

What is the DOI of this paper?

10.1093/jac/36.1.185, permanently at https://doi.org/10.1093/jac/36.1.185. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.